Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JonB
    Member
    • Jan 2010
    • 85

    #1

    Illumina RNA-seq: should I trim low quality bases prior to mapping?

    I have Illumina sequences from a cDNA sample. I want to map the reads to a reference genome and calculate expression levels. I think I will map using bowtie/tophat.

    The adaptors are removed from my sequences, but I wonder whether I need to trim away the low quality bases at the 3'-end of the reads? Or is this taken into account in the mapping?

    Thanks!
  • pbluescript
    Senior Member
    • Nov 2009
    • 224

    #2
    Tophat can sometimes have trouble mapping reads with a lot of low quality bases on the end. Trimming the reads might help with that, but shorter reads are more likely to map to multiple locations. If they are paired end reads, you will need to reassess your mean inner distance. Try it with and without the trimming and see which works best for your data.
    STAR is another alignment program you might consider trying that will automatically soft clip bases off a read if necessary to find a good alignment.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...